507.56 USD
▲+6.75+5.30%
2026-08-03
市值
$11.73B
市盈率
—
EPS
-14.22
股息率
—
52 周区间
290.00 – 615.00
成交量
442.34K
Beta
-1.00
目标价
682.93
52W 低 290.0052W 高 615.00
价格走势
公司简介
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.